BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4668744)

  • 1. [Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy].
    Girard PF; Trillet M; Kopp N
    Rev Neurol (Paris); 1972 Nov; 127(5):560-3. PubMed ID: 4668744
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594756
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594755
    [No Abstract]   [Full Text] [Related]  

  • 4. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 5. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of ornithine-ketoglutarate on provoked hyperammonaemia in patients with cirrhosis of the liver (author's transl)].
    Blahíková L; Horký J; Pechar J; Vidlaková M; Zvolánková K; Vosmík J; Marecková O
    Cesk Gastroenterol Vyz; 1978 Jun; 32(4):262-7. PubMed ID: 688420
    [No Abstract]   [Full Text] [Related]  

  • 7. [The blood ammonia electroencephalogram pattern in the evaluation of portosystemic encephalopathy].
    Bataller Sifre R; López Gómez LJ; Abella Llácer A; Berto Navarro R; González Marrtínez M
    Rev Esp Enferm Apar Dig; 1972 Feb; 36(3):293-304. PubMed ID: 5058815
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contribution to the treatment of portal systemic encephalopathy (author's transl)].
    Blahníková L; Horký J; Pechar J; Honzák R; Vosmík J
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):486-93. PubMed ID: 737756
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of 3,4-dihydroxyphenylalanine (levodopa) in hepatic coma].
    González-Posada J; Hernández-Peniche J; Tirado-Arroyave S
    Arch Invest Med (Mex); 1972; 3(1):1-6. PubMed ID: 5037838
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Flapping tremor" in hepatic encephalopathy. Physiopathological study].
    Molina-Negro P; Emond M; Hardy J
    Union Med Can; 1972 Feb; 101(2):242-6. PubMed ID: 4666312
    [No Abstract]   [Full Text] [Related]  

  • 11. Ornicetil on encephalopathy. Effect of ornicetil (ornithine alpha-ketoglutarate) on encephalopathy in patients with acute and chronic liver disease.
    Chainuvati T; Plengvanit U; Viranuvatti V
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):434-9. PubMed ID: 602619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nosology and therapy of hyperammonemia in liver diseases].
    Reinelt D; Schmidt P; Weinhold D
    Z Gesamte Inn Med; 1969 Aug; 24(15):480-3. PubMed ID: 5363188
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of ornighine alpha-ketoglutarate on hyperammoniemia in the cirrhotic patient].
    Michel H; Ogé P; Bertrand L
    Presse Med (1893); 1971 Apr; 79(19):867-8. PubMed ID: 5576498
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].
    Eisenburg J; Krumpoch B; Grunst J; Weinzierl M; Munte A; Schmidt S; Magerl W; Schauer S
    Fortschr Med; 1972 Aug; 90(24):837-48. PubMed ID: 4639347
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic encephalopathy: current status.
    Schenker S; Breen KJ; Hoyumpa AM
    Gastroenterology; 1974 Jan; 66(1):121-51. PubMed ID: 4588556
    [No Abstract]   [Full Text] [Related]  

  • 16. Cirrhosis, hyperammonemia and Lactulose.
    Rottiers R; Van Egmond J; Verbruggen R; Dierick G; Vermeulen A; Standaert L; De Groote J; Demeulenaere L
    Tijdschr Gastroenterol; 1968; 11(2):123-39. PubMed ID: 5679042
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
    Szám I; Szentner J; Hegedüs-Wein I; Vass A; Szilárd T
    Wien Med Wochenschr; 1974 May; 124(20):319-25. PubMed ID: 4829691
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of lactulose in the treatment of chronic porto-cave encephalopathy (20 cases)].
    Geffroy Y; Segrestin M; Geffroy PY
    Therapeutique; 1970 Nov; 46(9):897-901. PubMed ID: 5486138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of alpha ornithine ketoglutarate].
    Linquette M; Fossati P; Hubschman B
    Lille Med; 1969 Apr; 14():Suppl 3:512-5. PubMed ID: 5376446
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic value of ammonia in the cerebrospinal fluid in hepatic encephalopathy in cirrhotics].
    González Barón M; Barreiro P; camúñez F; Martínez A; Ortíz Vásquez J
    Rev Clin Esp; 1973 May; 129(3):239-44. PubMed ID: 4714683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.